{
  "clinicalImpactSubmission": [
    {
      "recordStatus": "novel",
      "localID": "civic.mpid:198",
      "localKey": "civic.eid:6034",
      "observedIn": [
        {
          "alleleOrigin": "somatic",
          "affectedStatus": "yes",
          "collectionMethod": "curation"
        }
      ],
      "conditionSet": {
        "condition": [
          {
            "db": "MONDO",
            "id": "0021657"
          }
        ]
      },
      "variantSet": {
        "variant": [
          {
            "hgvs": "ENST00000648323.1:c.402C>G",
            "gene": [
              {
                "id": 668
              }
            ]
          }
        ]
      },
      "clinicalImpactClassification": {
        "clinicalImpactClassificationDescription": "Tier I - Strong",
        "assertionTypeForClinicalImpact": "diagnostic: supports diagnosis",
        "comment": "FOXL2 mutations were found in 94% of pathologically confirmed A-GCTs (95/101), in one of eight juvenile granulosa cell tumours (J-GCTs), and in two of 19 SLCTs. ",
        "citation": [
          {
            "db": "PubMed",
            "id": "26033501"
          }
        ]
      }
    }
  ]
}
